Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
52 CHF | +1.56% | -6.47% | -27.37% |
Mar. 08 | Switzerland's Coltene Appoints Successor to Outgoing Chair | MT |
Mar. 08 | Switzerland's Coltene Logs Lower FY23 Net Profit, Sales | MT |
Summary
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- This company will be of major interest to investors in search of a high dividend stock.
- For the last few months, EPS revisions have remained quite promising. Analysts now anticipate higher profitability levels than before.
Weaknesses
- According to forecast, a sluggish sales growth is expected for the next fiscal years.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- For the past year, analysts have significantly revised downwards their profit estimates.
- Over the past four months, analysts' average price target has been revised downwards significantly.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-27.37% | 342M | B- | ||
-2.53% | 186B | C+ | ||
-3.52% | 106B | C | ||
-3.98% | 67.64B | A | ||
+5.33% | 50.39B | B- | ||
+16.43% | 47.65B | B- | ||
-1.73% | 39.29B | B+ | ||
+5.66% | 27.24B | A- | ||
-2.01% | 25.42B | B | ||
-1.87% | 24.54B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- CLTN Stock
- Ratings COLTENE Holding AG